8-K
Current Report
Alaunos Therapeutics, Inc. Filed Acc 0000950170-25-093263
Delisting notice · Executive or director change
- Item 3.01 Notice of delisting or failure to meet a listing standard
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading tcrt-20250701.htm…